These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 30653927)

  • 21. Nintedanib in patients with progressive fibrosing interstitial lung diseases-subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial.
    Wells AU; Flaherty KR; Brown KK; Inoue Y; Devaraj A; Richeldi L; Moua T; Crestani B; Wuyts WA; Stowasser S; Quaresma M; Goeldner RG; Schlenker-Herceg R; Kolb M;
    Lancet Respir Med; 2020 May; 8(5):453-460. PubMed ID: 32145830
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CT predictors of outcomes in patients with connective tissue disease and progressive lung fibrosis.
    Shou AY; Salvatore MM
    Clin Imaging; 2023 Feb; 94():42-49. PubMed ID: 36493681
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Progressive fibrosing interstitial lung disease: prevalence and clinical outcome.
    Kwon BS; Choe J; Chae EJ; Hwang HS; Kim YG; Song JW
    Respir Res; 2021 Oct; 22(1):282. PubMed ID: 34719401
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of characteristics of connective tissue disease-associated interstitial lung diseases, undifferentiated connective tissue disease-associated interstitial lung diseases, and idiopathic pulmonary fibrosis in Chinese Han population: a retrospective study.
    Pan L; Liu Y; Sun R; Fan M; Shi G
    Clin Dev Immunol; 2013; 2013():121578. PubMed ID: 24171031
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial.
    Behr J; Prasse A; Kreuter M; Johow J; Rabe KF; Bonella F; Bonnet R; Grohe C; Held M; Wilkens H; Hammerl P; Koschel D; Blaas S; Wirtz H; Ficker JH; Neumeister W; Schönfeld N; Claussen M; Kneidinger N; Frankenberger M; Hummler S; Kahn N; Tello S; Freise J; Welte T; Neuser P; Günther A;
    Lancet Respir Med; 2021 May; 9(5):476-486. PubMed ID: 33798455
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interstitial Lung Disease: A Review.
    Maher TM
    JAMA; 2024 May; 331(19):1655-1665. PubMed ID: 38648021
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Computed Tomography Findings Suggestive of Connective Tissue Disease in the Setting of Usual Interstitial Pneumonia.
    Chung JH; Montner SM; Thirkateh P; Cannon B; Barnett SD; Nathan SD
    J Comput Assist Tomogr; 2021 Sep-Oct 01; 45(5):776-781. PubMed ID: 34546682
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The potential utility of anterior upper lobe honeycomb-like lesion in interstitial lung disease associated with connective tissue disease.
    Yamakawa H; Ogura T; Sato S; Nishizawa T; Kawabe R; Oba T; Kato A; Horikoshi M; Akasaka K; Amano M; Kuwano K; Sasaki H; Baba T; Matsushima H
    Respir Med; 2020 Oct; 172():106125. PubMed ID: 32911135
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Idiopathic Interstitial Pneumonia Associated With Autoantibodies: A Large Case Series Followed Over 1 Year.
    Collins BF; Spiekerman CF; Shaw MA; Ho LA; Hayes J; Spada CA; Stamato CM; Raghu G
    Chest; 2017 Jul; 152(1):103-112. PubMed ID: 28300570
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A cluster-based analysis evaluating the impact of comorbidities in fibrotic interstitial lung disease.
    Wong AW; Lee TY; Johannson KA; Assayag D; Morisset J; Fell CD; Fisher JH; Shapera S; Gershon AS; Cox G; Halayko AJ; Hambly N; Manganas H; Sadatsafavi M; Wilcox PG; To T; Marcoux V; Khalil N; Kolb M; Ryerson CJ
    Respir Res; 2020 Dec; 21(1):322. PubMed ID: 33287805
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk of primary graft dysfunction following lung transplantation in selected adults with connective tissue disease-associated interstitial lung disease.
    Natalini JG; Diamond JM; Porteous MK; Lederer DJ; Wille KM; Weinacker AB; Orens JB; Shah PD; Lama VN; McDyer JF; Snyder LD; Hage CA; Singer JP; Ware LB; Cantu E; Oyster M; Kalman L; Christie JD; Kawut SM; Bernstein EJ
    J Heart Lung Transplant; 2021 May; 40(5):351-358. PubMed ID: 33637413
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Progressive Fibrosing Interstitial Lung Diseases: Prevalence and Characterization in Two Italian Referral Centers.
    Faverio P; Piluso M; De Giacomi F; Della Zoppa M; Cassandro R; Harari S; Luppi F; Pesci A
    Respiration; 2020; 99(10):838-845. PubMed ID: 33264777
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical Significance of Interstitial Lung Disease and Its Acute Exacerbation in Microscopic Polyangiitis.
    Hozumi H; Kono M; Hasegawa H; Yasui H; Suzuki Y; Karayama M; Furuhashi K; Enomoto N; Fujisawa T; Inui N; Nakamura Y; Yokomura K; Nakamura H; Suda T
    Chest; 2021 Jun; 159(6):2334-2345. PubMed ID: 33571506
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors influencing long-term outcomes in fibrotic interstitial lung disease (F-ILD) diagnosed through multidisciplinary discussion (MDD): a prospective cohort study.
    Liao YW; Liu MC; Wu YC; Hsu CY; Huang WN; Chen YH; Fu PK
    Eur J Med Res; 2024 Jan; 29(1):91. PubMed ID: 38291459
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnosis and Management of Fibrotic Interstitial Lung Diseases.
    Collins BF; Luppi F
    Clin Chest Med; 2021 Jun; 42(2):321-335. PubMed ID: 34024407
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined pulmonary fibrosis and emphysema as a clinicoradiologic entity: Characterization of presenting lung fibrosis and implications for survival.
    Alsumrain M; De Giacomi F; Nasim F; Koo CW; Bartholmai BJ; Levin DL; Moua T
    Respir Med; 2019 Jan; 146():106-112. PubMed ID: 30665507
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use of exhaled air analysis in discriminating interstitial lung diseases: a pilot study.
    Plantier L; Smolinska A; Fijten R; Flamant M; Dallinga J; Mercadier JJ; Pachen D; d'Ortho MP; van Schooten FJ; Crestani B; Boots AW
    Respir Res; 2022 Jan; 23(1):12. PubMed ID: 35057817
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Value of CT quantification in progressive fibrosing interstitial lung disease: a deep learning approach.
    Koh SY; Lee JH; Park H; Goo JM
    Eur Radiol; 2024 Jul; 34(7):4195-4205. PubMed ID: 38085286
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estimates of epidemiology, mortality and disease burden associated with progressive fibrosing interstitial lung disease in France (the PROGRESS study).
    Nasser M; Larrieu S; Boussel L; Si-Mohamed S; Bazin F; Marque S; Massol J; Thivolet-Bejui F; Chalabreysse L; Maucort-Boulch D; Hachulla E; Jouneau S; Le Lay K; Cottin V
    Respir Res; 2021 May; 22(1):162. PubMed ID: 34030695
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic factors and outcomes in Japanese lung transplant candidates with interstitial lung disease.
    Ikezoe K; Handa T; Tanizawa K; Chen-Yoshikawa TF; Kubo T; Aoyama A; Motoyama H; Hijiya K; Tokuda S; Nakatsuka Y; Yamamoto Y; Oshima A; Harashima SI; Nagai S; Hirai T; Date H; Chin K
    PLoS One; 2017; 12(8):e0183171. PubMed ID: 28800589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.